Pasar al contenido principal

ESTUDIO FUNCIONAL DEL EFECTO DE INHIBICION FARMACOLOGICA EN MODELO IN VIVO MURINO DE CELULAS PRIMARIAS DE SINDROME DE SEZARY (LINFOMA CUTANEO DE CELULAS T)

PI18/00021

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2018
Plan Estatal 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (FIMIM)
Centro realización INSTITUTO HOSPITAL DEL MAR DE INVESTIGACIONES MEDICAS (IMIM)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Sézary syndrome patient-derived models allow drug selection for personalized therapy

  • Gallardo, Fernando|||0000-0002-8996-3828
  • Andrades, Evelyn|||0000-0003-2166-6760
  • Iglesias, Arnau|||0000-0002-7195-7868
  • González Miranda, Jessica|||0000-0001-7732-1564
  • Solé Font, Laura|||0000-0002-3195-0565
  • Guillén, Yolanda|||0000-0001-8673-6470
  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Colomo, Luis|||0000-0001-5236-5085
  • Gimeno, Eva|||0000-0002-3534-6189
  • Conde Estévez, David|||0000-0002-9414-9409
  • Rodríguez García, Eva
  • Bielsa, Isabel
  • Iglesias, Mar|||0000-0002-2274-4671
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Regueiro, José R.|||0000-0001-8442-7762
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Espinosa, Lluis|||0000-0002-2897-4099
Current therapeutic approaches for Sézary syndrome (SS) do not achieve a significant improvement in long-term survival of patients, and they are mainly focused on reducing blood tumor burden to improve quality of life. Eradication of SS is hindered by its genetic and molecular heterogeneity. Determining effective and personalized treatments for SS is urgently needed. The present work compiles the current methods for SS patient-derived xenograft (PDX) generation and management to provide new perspectives on treatment for patients with SS. Mononuclear cells were recovered by Ficoll gradient separation from fresh peripheral blood of patients with SS (N 5 11). A selected panel of 26 compounds that are inhibitors of the main signaling pathways driving SS pathogenesis, including NF-kB, MAPK, histone deacetylase, mammalian target of rapamycin, or JAK/STAT, was used for in vitro drug sensitivity testing. SS cell viability was evaluated by using the CellTiter-Glo_3D Cell Viability Assay and flow cytometry analysis. We validated one positive hit using SS patient-derived Sézary cells xenotransplanted (PDX) into NOD-SCID-g mice. In vitro data indicated that primary malignant SS cells all display different sensitivities against specific pathway inhibitors. In vivo validation using SS PDX mostly reproduced the responses to the histone deacetylase inhibitor panobinostat that were observed in vitro. Our investigations revealed the possibility of using high-throughput in vitro testing followed by PDX in vivo validation for selective targeting of SS tumor cells in a patient-specific manner.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High-throughput RNA sequencing of the T cell receptor alpha and beta chains for simultaneous clonality and biological analyses in Sezary syndrome

  • Blanco, Gonzalo|||0000-0001-6557-3764
  • López Aventín, Daniel|||0000-0001-5097-5621
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Gómez-Llonín, Andrea|||0000-0002-7470-6730
  • Puiggros, Anna|||0000-0001-9627-4978
  • López-Sánchez, Manuela|||0000-0002-5094-0266
  • Estrach, Teresa|||0000-0002-4601-2811
  • Garcia Muret, Maria Pilar|||0000-0003-1714-5815
  • Lopez-Lerma, Ingrid|||0000-0002-7690-8926
  • Servitje, Octavio|||0000-0002-9910-9617
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Muro, Manuel|||0000-0001-9987-0994
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Rabionet, Raquel|||0000-0001-5006-8140
  • Gallardo, Fernando|||0000-0002-8996-3828
Previous investigations pointed out a role for antigen stimulation in Sezary syndrome (SS). High-throughput sequencing of the T cell receptor (TR) offers several applications beyond diagnostic purposes, including the study of T cell pathogenesis. We performed high-throughput RNA sequencing of the TR alpha (TRA) and beta (TRB) genes focusing on the complementarity-determining region 3 (CDR3) in 11 SS and one erythrodermic mycosis fungoides (MF) patients. Five psoriasis patients were employed as controls. Peripheral blood CD4 + cells were isolated and RNA sequenced (HiSeq2500). High-resolution HLA typing was performed in neoplastic patients. Highly expanded predominant TRA and TRB CDR3 were only found in SS patients (median frequency: 94.4% and 93.7%). No remarkable CDR3 expansions were observed in psoriasis patients (median frequency of predominant TRA and TRB CDR3: 0.87% and 0.69%, p < 0.001 compared to SS). CDR3 almost identical to the predominant were identified within each SS patient and were exponentially correlated with frequencies of the predominant CDR3 (R 2 = 0.918, p < 0.001). Forty-six different CDR3 were shared between SS patients displaying HLA similarities, including predominant TRA and TRB CDR3 in one patient that were found in other three patients. Additionally, 351 antigen matches were detected (Cytomegalovirus, Epstein-Barr, Influenza virus, and self-antigens), and the predominant CDR3 of two different SS patients matched CDR3 with specificity for Influenza and Epstein-Barr viruses. Besides detecting clonality, these findings shed light on the nature of SS-related antigens, pointing to RNA sequencing as a useful tool for simultaneous clonality and biological analysis in SS. We performed RNA sequencing of TR alpha (TRA) and beta (TRB) in peripheral blood CD4 + T cells from Sezary Syndrome (SS) and psoriasis patients (PS) employed as controls and found correlated (A) and highly expanded predominant TRA and TRB complementarity-determining regions 3 (CDR3) only in SS patients (B). CDR3 almost identical to the predominant were identified within each SS patient and were exponentially correlated with frequencies of the predominant CDR3 (C), and shared CDR3 (D) enriched in antigen matches between different patients (including CMV, Epstein-Barr virus, Influenza virus and self-antigens) were also detected (E). Besides detecting clonality, these findings shed light on the nature of SS-related antigens, pointing to RNA sequencing as a useful tool for simultaneous clonality and biological analysis in SS.